sábado, 2 de mayo de 2020

BMC Cancer | Articles

BMC Cancer | Articles



  1. Women with ductal carcinoma in situ (DCIS) report poor patient-clinician communication, and long-lasting confusion and anxiety about their treatment and prognosis. Research shows that patient-centred care (PCC...
    Authors:Bryanna B. Nyhof, Frances C. Wright, Nicole J. Look Hong, Gary Groot, Lucy Helyer, Pamela Meiers, May Lynn Quan, Nancy N. Baxter, Robin Urquhart, Rebecca Warburton and Anna R. Gagliardi
    Citation:BMC Cancer 2020 20:364
    Content type:Research article
    Published on: 
  2. Conversion surgery (CS) following a response to chemotherapy occasionally leads to prolonged survival in patients with stage IV gastric cancer (GC). This study aimed to evaluate the predictive value of the neu...
    Authors:Naohiko Nakamura, Shinichi Kinami, Yasuto Tomita, Takashi Miyata, Hideto Fujita, Hiroyuki Takamura, Nobuhiko Ueda and Takeo Kosaka
    Citation:BMC Cancer 2020 20:363
    Content type:Research article
    Published on: 
  3. A substantial number of patients will develop further biochemical progression after radical prostatectomy (RP) and salvage radiotherapy (sRT). Recently published data using prostate-specific membrane antigen l...
    Authors:Ann-Kathrin Oehus, Stephanie G. C. Kroeze, Nina-Sophie Schmidt-Hegemann, Marco M. E. Vogel, Simon Kirste, Jessica Becker, Irene A. Burger, Thorsten Derlin, Peter Bartenstein, Matthias Eiber, Michael Mix, Christian la Fougère, Claus Belka, Stephanie E. Combs, Anca-Ligia Grosu, Arndt-Christian Müller…
    Citation:BMC Cancer 2020 20:362
    Content type:Research article
    Published on: 
  4. The prognostic nutritional index (PNI), an immunity and nutrition based prognostic score, was correlated with clinical outcomes in different tumors. However, the prognostic significance of PNI has not been inv...
    Authors:Bin Li, Zheng Lu, Shengzheng Wang, Junqing Hou, Gang Xia, Heng Li, Bo Yin and Wei Lu
    Citation:BMC Cancer 2020 20:361
    Content type:Research article
    Published on: 
  5. Dysphagia or difficulty in swallowing affects quality of life for most patients with head and neck cancer. SIP SMART – [Swallowing Intervention Package: Self-Monitoring, Assessment, Rehabilitation Training] ai...
    Authors:Roganie Govender, Christina H. Smith, Helen Barratt, Benjamin Gardner and Stuart A. Taylor
    Citation:BMC Cancer 2020 20:360
    Content type:Research article
    Published on: 
  6. Therapy targeted to the human epidermal growth factor receptor type 2 (HER2) is used in combination with cytotoxic therapy in treatment of HER2+ breast cancer. Trastuzumab, a monoclonal antibody that targets H...
    Authors:Meghan J. Bloom, Angela M. Jarrett, Todd A. Triplett, Anum K. Syed, Tessa Davis, Thomas E. Yankeelov and Anna G. Sorace
    Citation:BMC Cancer 2020 20:359
    Content type:Research article
    Published on: 
  7. This study aimed to evaluate the efficacy and the safety of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing neutropenia in metastatic colorectal cancer (mCRC) pa...
    Authors:Yusuke Kitagawa, Hiroki Osumi, Eiji Shinozaki, Yumiko Ota, Izuma Nakayama, Takeshi Suzuki, Takeru Wakatsuki, Mariko Ogura, Akira Ooki, Daisuke Takahari, Mitsukuni Suenaga, Keisho Chin and Kensei Yamaguchi
    Citation:BMC Cancer 2020 20:358
    Content type:Research article
    Published on: 
  8. The objective of this study was to investigate real-world EGFR mutation testing in patients with metastatic non-small cell lung cancer (NSCLC) upon progression on first−/second-generation epidermal growth fact...
    Authors:Anne C. Chiang, Ancilla W. Fernandes, Melissa Pavilack, Jennifer W. Wu, François Laliberté, Mei Sheng Duh, Nabil Chehab and Janakiraman Subramanian
    Citation:BMC Cancer 2020 20:356
    Content type:Research article
    Published on: 
  9. This analysis aims at evaluating the impact of multidisciplinary tumor boards on clinical outcome of multiple tumor entities, the effect of the specific number of multidisciplinary tumor boards and potential d...
    Authors:Marius Freytag, Ulrich Herrlinger, Stefan Hauser, Franz G. Bauernfeind, Maria A. Gonzalez-Carmona, Jennifer Landsberg, Jens Buermann, Hartmut Vatter, Tobias Holderried, Thorsten Send, Martin Schumacher, Arne Koscielny, Georg Feldmann, Mario Heine, Dirk Skowasch, Niklas Schäfer…
    Citation:BMC Cancer 2020 20:355
    Content type:Research article
    Published on: 
  10. Tumor recurrence and metastasis occur at a high rate in patients with colon cancer. Identification of effective strategies for the treatment of colon cancer is critical. Recently, poly (lactic-co-glycolic acid...
    Authors:Pingping Wu, Qing Zhou, Huayun Zhu, Yan Zhuang and Jun Bao
    Citation:BMC Cancer 2020 20:354
    Content type:Research article
    Published on: 
  11. High-dose (HD) chemotherapy followed by autologous blood stem-cell transplantation (ASCT) is the standard treatment for multiple myeloma (MM) patients. However, the collection of sufficient peripheral blood st...
    Authors:Sandra Sauer, Petra Pavel, Anita Schmitt, Martin Cremer, Mark Kriegsmann, Thomas Bruckner, Karin Jordan, Patrick Wuchter, Carsten Müller-Tidow and Katharina Kriegsmann
    Citation:BMC Cancer 2020 20:353
    Content type:Research article
    Published on: 
  12. Modified docetaxel, cisplatin, and 5-fluorouracil (mDCF) regimen has become a new standard for the treatment of metastatic or unresectable locally advanced recurrent squamous cell carcinoma of the anus (SCCA) ...
    Authors:Stefano Kim, Bruno Buecher, Thierry André, Marine Jary, François-Clément Bidard, François Ghiringhelli, Éric François, Julien Taieb, Denis Smith, Christelle de la Fouchardière, Jérôme Desramé, Emmanuelle Samalin, Aurélie Parzy, Nabil Baba-Hamed, Olivier Bouché, David Tougeron…
    Citation:BMC Cancer 2020 20:352
    Content type:Study protocol
    Published on: 
  13. The number of people living with soft-tissue and bone sarcomas is increasing due to improved individual therapy and changes in demographics. At present, there are no recommendations for psychological co-treatm...
    Authors:Wolfram Weschenfelder, Sabine Gast-Froehlich, Christian Spiegel, Matthias Vogt and Gunther O. Hofmann
    Citation:BMC Cancer 2020 20:351
    Content type:Research article
    Published on: 
  14. ARID1A has been described as a tumor suppressor gene, participating in chromatin re-modeling, epithelial-mesenchymal-transition and many other cellular and molecular processes. It has been cited as a contribut...
    Authors:Mehran Erfani, Seyed Vahid Hosseini, Maral Mokhtari, Mozhdeh Zamani, Kamran Tahmasebi, Mahvash Alizadeh Naini, Alireza Taghavi, John M. Carethers, Minoru Koi, Hassan Brim, Pooneh Mokarram and Hassan Ashktorab
    Citation:BMC Cancer 2020 20:350
    Content type:Research article
    Published on: 
  15. Testicular germ cell tumours (TGCTs) are characterised by an overall high cisplatin-sensitivity which has been linked to their continued expression of pluripotency factors. Recently, the Nodal signalling pathw...
    Authors:K. Harpelunde Poulsen, J. E. Nielsen, B. Grønkær Toft, U. N. Joensen, L. J. Rasmussen, M. Blomberg Jensen, R. T. Mitchell, A. Juul, E. Rajpert-De Meyts and A. Jørgensen
    Citation:BMC Cancer 2020 20:349
    Content type:Research article
    Published on: 
  16. The relationships among PIK3CA mutations, medication use and tumor progression remains poorly understood. Aspirin use post-diagnosis may modify components of the PI3K pathway, including AKT and mTOR, and has been...
    Authors:Anne Marie McCarthy, Nitya Pradeep Kumar, Wei He, Susan Regan, Michaela Welch, Beverly Moy, A. John Iafrate, Andrew T. Chan, Aditya Bardia and Katrina Armstrong
    Citation:BMC Cancer 2020 20:347
    Content type:Research article
    Published on: 
  17. Familial colorectal cancer type X (FCCTX) is a phenotypically defined subset of hereditary colorectal cancer with unknown and potentially heterogeneous genetic aetiology. FCCTX has been characterized as a colo...
    Authors:Christina Therkildsen, Maria Rasmussen, Lars Smith-Hansen, Thomas Kallemose, Lars Joachim Lindberg and Mef Nilbert
    Citation:BMC Cancer 2020 20:345
    Content type:Research article
    Published on: 
  18. Detection of programmed cell death ligand-1 (PD-L1) by immunohistochemistry (IHC) has been commonly used to predict the efficacy of treatment with PD-1/PD-L1 inhibitors. However, there is limited literature re...
    Authors:Yinying Zou, Liming Xu, Qiusu Tang, Qihan You, Xiaoling Wang, Wei Ding, Jing Zhao and Guoping Ren
    Citation:BMC Cancer 2020 20:344
    Content type:Research article
    Published on: 
  19. Planar-based measurements of lesions in metastatic melanoma have limitations in estimating tumor burden of a patient and in predicting response to treatment. Volumetric imaging might add predictive value to Re...
    Authors:Arwa Ali, Monica Dumbrava, Kylie Riddell, Nina Stewart, Robyn Ward, Ahmed K. Ibrahim and Melvin Chin
    Citation:BMC Cancer 2020 20:342
    Content type:Research article
    Published on: 
  20. Antigen-processing machinery molecules play crucial roles in infectious diseases and cancers. Studies have shown that polymorphisms in endoplasmic reticulum aminopeptidase (ERAP) genes can influence the enzyma...
    Authors:Chuanyin Li, Yaheng Li, Zhiling Yan, Shuying Dai, Shuyuan Liu, Xia Wang, Jun Wang, Xinwen Zhang, Li Shi and Yufeng Yao
    Citation:BMC Cancer 2020 20:341
    Content type:Research article
    Published on: 
  21. To examine the tumor characteristics, treatments and survival outcomes of prostate cancer (PCa) patients with a prostate-specific antigen (PSA) level < 4 ng/ml.
    Authors:Zhibo Zheng, Zhien Zhou, Weigang Yan, Yi Zhou, Chuyan Chen, Hanzhong Li and Zhigang Ji
    Citation:BMC Cancer 2020 20:340
    Content type:Research article
    Published on: 
  22. Patients with metastatic renal cell cancer (mRCC) are commonly treated with the tyrosine kinase inhibitor sunitinib, which blocks signalling from vascular endothelial growth factor (VEGF) - and platelet-derive...
    Authors:Marjut Niinivirta, Maria Georganaki, Gunilla Enblad, Cecilia Lindskog, Anna Dimberg and Gustav J. Ullenhag
    Citation:BMC Cancer 2020 20:339
    Content type:Research article
    Published on: 
  23. Ramucirumab monotherapy as a second-line treatment for advanced gastric cancer (AGC) prolongs survival compared to the best supportive care. However, in clinical practice, ramucirumab monotherapy is sometimes ...
    Authors:Sadayuki Kawai, Naoki Fukuda, Shun Yamamoto, Seiichiro Mitani, Katsuhiro Omae, Takeru Wakatsuki, Ken Kato, Shigenori Kadowaki, Daisuke Takahari, Narikazu Boku, Kei Muro and Nozomu Machida
    Citation:BMC Cancer 2020 20:338
    Content type:Research article
    Published on: 
  24. The standard treatment for patients with unresectable locally advanced esophageal squamous cell carcinoma (ESCC) is definitive chemoradiotherapy (CRT) using 5-FU plus cisplatin. However, complete response (CR)...
    Authors:Hideaki Bando, Daisuke Kotani, Takahiro Tsushima, Hiroki Hara, Shigenori Kadowaki, Ken Kato, Keisho Chin, Kensei Yamaguchi, Shun-ichiro Kageyama, Hidehiro Hojo, Masaki Nakamura, Hidenobu Tachibana, Masashi Wakabayashi, Miki Fukutani, Yosuke Togashi, Nozomu Fuse…
    Citation:BMC Cancer 2020 20:336
    Content type:Study protocol
    Published on: 
  25. Cancer patients often receive multiple drugs to maximize their therapeutic benefit, treat co-morbidities and counter the adverse effects of chemotherapy. Concomitant administration of multiple drugs increases ...
    Authors:Mohammad Ismail, Sehrash Khan, Fahadullah Khan, Sidra Noor, Hira Sajid, Shazia Yar and Irum Rasheed
    Citation:BMC Cancer 2020 20:335
    Content type:Research article
    Published on: 
  26. Unplanned hospitalization during cancer treatment is costly, can disrupt treatment, and affect patient quality of life. However, incidence and risks factors for hospitalization during lung cancer radiotherapy ...
    Authors:Sarah Z. Hazell, Nicholas Mai, Wei Fu, Chen Hu, Cole Friedes, Alex Negron, Khinh Ranh Voong, Josephine L. Feliciano, Peijin Han, Samantha Myers, Todd R. McNutt and Russell K. Hales
    Citation:BMC Cancer 2020 20:334
    Content type:Research article
    Published on: 
  27. Breast cancer treatment is tailored to the specific cancer subtype. Often, systemic treatment is given prior to surgery. Chemotherapy induces significant endoplasmic reticulum (ER) stress-mediated cell death a...
    Authors:Annat Raiter, Julia Lipovetzki, Ido Lubin and Rinat Yerushalmi
    Citation:BMC Cancer 2020 20:333
    Content type:Research article
    Published on: 
  28. Hepatocellular carcinoma (HCC) is the leading cause of cancer-related deaths worldwide. The only drug currently approved for clinical use in the treatment of advanced HCC is sorafenib. However, many patients w...
    Authors:Hanhee Jo, Yusun Park, Taehun Kim, Jisu Kim, Jong Sook Lee, Seon Yoo Kim, Jee-in Chung, Hae yong Ko, Jae-Chul Pyun, Kyung Sik Kim, Misu Lee and Mijin Yun
    Citation:BMC Cancer 2020 20:332
    Content type:Research article
    Published on: 
  29. The gene encoding fibroblast growth factor receptor 1 (FGFR1) is emerging as a therapeutic and prognostic biomarker in various cancer types, including head and neck squamous cell carcinoma (SCC). Here, we investi...
    Authors:Eun Kyung Kim, Yoon Ah Cho, Yoon Woo Koh, Hyang Ae Shin, Byoung Chul Cho and Sun Och Yoon
    Citation:BMC Cancer 2020 20:348
    Content type:Research article
    Published on: 
  30. Stereotactic irradiation (STI) is a primary treatment for patients with newly diagnosed brain metastases. Some of these patients experience local progression, which is difficult to differentiate from radiation...
    Authors:Koichi Mitsuya, Yoko Nakasu, Nakamasa Hayashi, Shoichi Deguchi, Takuma Oishi, Takashi Sugino, Kazuaki Yasui, Hirofumi Ogawa, Tsuyoshi Onoe, Hirofumi Asakura and Hideyuki Harada
    Citation:BMC Cancer 2020 20:331
    Content type:Research article
    Published on: 
  31. Pelvic lymph node dissection (PLND) is one of the most important steps in radical prostatectomy (RP). Not only can PLND provide accurate clinical staging to guide treatment after prostatectomy but PLND can als...
    Authors:Jia-Jun Chen, Zai-Sheng Zhu, Yi-Yi Zhu and Hong-Qi Shi
    Citation:BMC Cancer 2020 20:330
    Content type:Research article
    Published on: 
  32. The prognostic significance of TP53 concurrent mutations in patients with epidermal growth factor receptor (EGFR)- or anaplastic lymphoma kinase (ALK)- mutated advanced non–small-cell lung cancer (NSCLC) who r...
    Authors:Kang Qin, Helei Hou, Yu Liang and Xiaochun Zhang
    Citation:BMC Cancer 2020 20:328
    Content type:Research article
    Published on: 
  33. To discuss some inaccurate parts of a published systematic review and meta-analysis which was about comparison of laparoscopic pancreaticoduodenectomy and open pancreaticoduodenectomy for pancreatic ductal ade...
    Authors:Rui Sun, Yifan Zhang and Zhe Su
    Citation:BMC Cancer 2020 20:327
    Content type:Correspondence
    Published on: 
    The original article was published in BMC Cancer 2019 19:781
  34. Neuroendocrine tumors (NETs) frequently overexpress somatostatin receptors (SSTRs), which is the molecular basis for 68Ga-DOTATOC positron-emission tomography (PET) and radiopeptide therapy (PRRT). However, SSTR ...
    Authors:Manuel Weber, Lukas Kessler, Benedikt Schaarschmidt, Wolfgang Peter Fendler, Harald Lahner, Gerald Antoch, Lale Umutlu, Ken Herrmann and Christoph Rischpler
    Citation:BMC Cancer 2020 20:326
    Content type:Research article
    Published on: 
  35. Sodium channels located in the dorsal root ganglion, particularly Nav1.7 and Nav1.8, encoded by SCN9A and SCN10A, respectively, act as molecular gatekeepers for pain detection. Our aim was to determine the associ...
    Authors:Yuko Tanabe, Seiji Shiraishi, Kenji Hashimoto, Kazutaka Ikeda, Daisuke Nishizawa, Junko Hasegawa, Akihiko Shimomura, Yukinori Ozaki, Nobuko Tamura, Mayu Yunokawa, Kan Yonemori, Toshimi Takano, Hidetaka Kawabata, Kenji Tamura, Yasuhiro Fujiwara and Chikako Shimizu
    Citation:BMC Cancer 2020 20:325
    Content type:Research article
    Published on: 
  36. The aim of this systematic review and meta-analysis was to compare overall survival and disease-free survival after fertility sparing surgery (FSS) vs radical surgery in stage 1 epithelial ovarian cancer (EOC).
    Authors:Denghua Liu, Jing Cai, Aiwei Gao, Zehua Wang and Liqiong Cai
    Citation:BMC Cancer 2020 20:320
    Content type:Research article
    Published on: 
  37. Pancreatic cancer is a devastating disease with a dismal prognosis. Despite profound medical advances in systemic therapies for other types of aggressive tumours during recent years, a diagnosis of pancreatic ...
    Authors:Sofie Olsson Hau, Alexandra Petersson, Björn Nodin, Emelie Karnevi, Karolina Boman, Caroline Williamsson, Jakob Eberhard, Karin Leandersson, David Gisselsson, Margareta Heby and Karin Jirström
    Citation:BMC Cancer 2020 20:308
    Content type:Study protocol
    Published on: 
  38. Colon adenocarcinoma (COAD) is one of the most lethal cancers. It is particularly important to accurately predict prognosis and to provide individualized treatment. Several lines of evidence suggest that genet...
    Authors:Xueying Li, Weiming Yu, Chao Liang, Yuan Xu, Miaozun Zhang, Xiaoyun Ding and Xianlei Cai
    Citation:BMC Cancer 2020 20:305
    Content type:Research article
    Published on: 

No hay comentarios:

Publicar un comentario